For example, not only are SMOC1 and SPON1 increased in CSF upwards of 30 years in advance of AD [17], these proteins are also increased in the preclinical or asymptomatic stage of disease in brain, suggesting each as high value biomarkers if detected in plasma [11]. This evidence concerns the gene SMOC1 and Alzheimer disease.